相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Karrune V. Woan et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
The GP2 peptide: A HER2/neu-based breast cancer vaccine
Kevin S. Clive et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Utility of Characteristic QTOF MS/MS Fragmentation for MHC Class I Peptides
Hernando Escobar et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and S
Martin L. Biniossek et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Oral valproic acid for epilepsy -: long-term experience in therapy and side effects
Thorsten Gerstner et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models
Edward F. Rosloniec et al.
JOURNAL OF AUTOIMMUNITY (2006)
Personalized peptide vaccines: A new therapeutic modality for cancer
Kyogo Itoh et al.
CANCER SCIENCE (2006)
The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules
C Watts
NATURE IMMUNOLOGY (2004)
Absence of γ-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes
MA Haque et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation
CS Hsieh et al.
JOURNAL OF IMMUNOLOGY (2002)
Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation
A Osborne et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors
WJ Magner et al.
JOURNAL OF IMMUNOLOGY (2000)